Literature DB >> 6977269

Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases.

C J Homcy, R R Liberthson, J T Fallon, S Gross, L M Miller.   

Abstract

To clarify the clinical spectrum of coronary arterial abnormalities in systemic lupus erythematosus, the data were reviewed on six patients who had a diagnosis of lupus at ages 15 to 29 years and who had ischemic heart disease before age 35. Two patients had coronary arteritis diagnosed on postmortem examination. In a third patient alterations in coronary arterial anatomy occurred with angiographic improvement temporally related to the initiation of steroid therapy. The other three patients had severe diffuse atherosclerotic coronary disease that was identified in two at postmortem examination. In the third patient the course of the disease strongly suggested coronary atherosclerosis, and eventually coronary bypass grafting was performed for relief of angina. In summary, clinically important extramural coronary arteritis and atherosclerosis both occur, although rarely, in young patients with lupus. Coronary artery disease may occur with or without coexisting active extracardiac lupus manifestations. Short-term steroid therapy and follow-up angiography for those with angina and in whom coronary arteritis is suspected warrant consideration. When stable coronary arterial anatomy is demonstrated on follow-up angiography, management is determined by the patient's symptoms irrespective of the prior history of lupus and, if indicated, cardiac surgery for symptomatic relief can be safely performed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977269     DOI: 10.1016/0002-9149(82)90528-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Corticosteroids: do they damage the cardiovascular system?

Authors:  S R Maxwell; R J Moots; M J Kendall
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

2.  Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus.

Authors:  A J MacGregor; V B Dhillon; A Binder; C A Forte; B C Knight; D J Betteridge; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus.

Authors:  Y Maaravi; E Raz; D Gilon; A Rubinow
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

4.  Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities.

Authors:  K Nagasawa; Y Ishii; T Mayumi; Y Tada; A Ueda; Y Yamauchi; T Kusaba; Y Niho
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

5.  A rare case of acute myocardial infarction with a non-specific symptom in a young female with systemic lupus erythematosus.

Authors:  Tomo Komaki; Shin-Ichiro Miura; Kouki Gondo; Ayumi Nakamura; Amane Ike; Akira Matsunaga; Keijiro Saku
Journal:  J Cardiol Cases       Date:  2017-06-09

6.  Coronary artery bypass grafting in patients with systemic lupus erythematosus. Report of 2 cases.

Authors:  R G Rinaldi; J Carballido; B Betancourt; M Sartori; E A Almodóvar
Journal:  Tex Heart Inst J       Date:  1995

7.  [Successful surgical treatment of atrial septal defect with systemic lupus erythematosis in a 47-year-old female].

Authors:  T Okamura; S Yokoyama; E Koh
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08

8.  Heart disease in systemic lupus erythematosus: diagnosis and management.

Authors:  A Ansari; P H Larson
Journal:  Tex Heart Inst J       Date:  1985-03

9.  Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction.

Authors:  E Arbustini; M Grasso; R Fasani; C Klersy; M Diegoli; E Porcu; N Banchieri; P Fortina; C Danesino; G Specchia
Journal:  Br Heart J       Date:  1995-12

10.  Endomyocardial biopsy in diagnosis and management of cardiovascular manifestations of systemic lupus erythematosus (SLE).

Authors:  C Tamburino; C E Fiore; R Foti; E Salomone; R Di Paola; D R Grimaldi
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.